Seagen Inc. SGEN
Set alert
228.74 +228.74 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 43.15B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -156.67
- Beta
- 0.32
- Short ratio
- 8.69
- Inst. own
- 88.83%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 1, 2023
- 50-d avg
- 217.43
- 200-d avg
- 204.65
- 1y target
- 229.00
Analyst view
Consensus: buy
Buy
Price target (mean) 229.00
Ratings (0m) 16 8 buy · 8 hold · 0 sell
- Strong buy3
- Buy5
- Hold8
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 17
- 2 months ago 17
- 3 months ago 23
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.00 | -1.25 – -0.81 | -0.80 | -25.0% | 683.21M | +29.4% | 6 |
| Next quarter | -0.72 | -0.72 – -0.72 | -0.93 | +22.6% | 678.33M | +30.5% | 1 |
| Current year | -4.21 | -4.48 – -4.02 | -3.30 | -27.6% | 2.46B | +25.2% | 6 |
| Next year | -1.46 | -2.12 – -0.66 | -4.21 | +65.3% | 3.31B | +34.8% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 17, 2023 | Truist Securities | Reiterated | Hold | Hold |
| Sep 24, 2023 | Truist Securities | Reiterated | Hold | Hold |
| Aug 2, 2023 | Morgan Stanley | Reiterated | Equal-Weight | Equal-Weight |
| Mar 23, 2023 | Berenberg | Downgrade | Buy | Hold |
| Mar 20, 2023 | TD Securities | Maintained | — | Market Perform |
| Mar 19, 2023 | Truist Securities | Maintained | — | Hold |
| Mar 14, 2023 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Mar 13, 2023 | BMO Capital | Downgrade | Outperform | Market Perform |
| Mar 13, 2023 | Needham | Downgrade | Buy | Hold |
| Mar 13, 2023 | Raymond James | Downgrade | Strong Buy | Market Perform |
| Mar 13, 2023 | Barclays | Maintained | — | Equal-Weight |
| Mar 13, 2023 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Mar 13, 2023 | RBC Capital | Maintained | — | Outperform |
| Mar 13, 2023 | Oppenheimer | Maintained | — | Outperform |
| Mar 12, 2023 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Mar 5, 2023 | Needham | Maintained | — | Buy |
| Feb 27, 2023 | Guggenheim | Reiterated | — | Buy |
| Feb 27, 2023 | Oppenheimer | Maintained | — | Outperform |
| Feb 22, 2023 | Needham | Maintained | — | Buy |
| Feb 20, 2023 | Oppenheimer | Maintained | — | Outperform |
| Feb 16, 2023 | JMP Securities | Maintained | — | Market Outperform |
| Feb 16, 2023 | Oppenheimer | Maintained | — | Outperform |
| Feb 15, 2023 | Morgan Stanley | Maintained | — | Overweight |
| Feb 15, 2023 | BMO Capital | Maintained | — | Outperform |
| Feb 15, 2023 | RBC Capital | Maintained | — | Outperform |
| Feb 15, 2023 | Needham | Reiterated | — | Buy |
| Feb 15, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 15, 2023 | Evercore ISI Group | Upgrade | In-Line | Outperform |
| Feb 15, 2023 | Raymond James | Upgrade | Outperform | Strong Buy |
| Feb 12, 2023 | JP Morgan | Maintained | — | Overweight |